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Abstract
A range of novel carboxamide fungicides, inhibitors of the succinate dehydrogenase enzyme (SDH, EC 1.3.5.1) is currently
being introduced to the crop protection market. The aim of this study was to explore the impact of structurally distinct
carboxamides on target site resistance development and to assess possible impact on fitness. We used a UV mutagenesis
approach in Mycosphaerella graminicola, a key pathogen of wheat to compare the nature, frequencies and impact of target
mutations towards five subclasses of carboxamides. From this screen we identified 27 amino acid substitutions occurring at
18 different positions on the 3 subunits constituting the ubiquinone binding (Qp) site of the enzyme. The nature of
substitutions and cross resistance profiles indicated significant differences in the binding interaction to the enzyme across
the different inhibitors. Pharmacophore elucidation followed by docking studies in a tridimensional SDH model allowed us
to propose rational hypotheses explaining some of the differential behaviors for the first time. Interestingly all the
characterized substitutions had a negative impact on enzyme efficiency, however very low levels of enzyme activity
appeared to be sufficient for cell survival. In order to explore the impact of mutations on pathogen fitness in vivo and in
planta, homologous recombinants were generated for a selection of mutation types. In vivo, in contrast to previous studies
performed in yeast and other organisms, SDH mutations did not result in a major increase of reactive oxygen species levels
and did not display any significant fitness penalty. However, a number of Qp site mutations affecting enzyme efficiency
were shown to have a biological impact in planta. Using the combined approaches described here, we have significantly
improved our understanding of possible resistance mechanisms to carboxamides and performed preliminary fitness penalty
assessment in an economically important plant pathogen years ahead of possible resistance development in the field.
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Introduction
Mycosphaerella graminicola (Fu ¨ckel) J. Schro ¨t. in Cohn (anamorph
Septoria tritici) is the causal agent of Septoria leaf blotch (STB), a
major threat to bread and durum wheat worldwide [1,2,3].
Breeding programs are ongoing to stack host resistance genes and
create new varieties highly resistant to STB, but current control of
this fungal disease relies heavily on fungicide use. Options for the
chemical control of STB were decreased recently after the rapid
development of resistance against the QoI fungicides in this
pathogen [4,5,6]. For QoIs, the resistance mechanism was
attributed to target site mutations in the Cytb gene of the target
enzyme Cytochrome C reductase also known as the respiratory
channel complex III [7]. Mainly, two amino acid substitutions
namely F129L and G143A in the mitochondrial CytB protein
were detected in field pathogens and these substitutions are
responsible for the dramatic loss of efficacy observed for this whole
class of fungicides. Currently, the great majority of the European
M. graminicola population carries the G143A mutation, making its
control highly reliant on C14-demethylase inhibitors (DMI) usage
targeting the ergosterol biosynthesis pathway and on the multisite
fungicide chlorothalonil (CTN). Gradual shifts in DMI sensitivity
observed as an incremental reduction in sensitivity of pathogen
population towards DMIs over time [8] further stress the
importance of introducing novel modes of action for STB control.
The availability of compounds with different modes of action is an
essential component for effective anti-resistance strategies contrib-
uting to wheat yield security [9].
The introduction of novel carboxamide fungicides has delivered
a major mode of action to almost all fungicide market segments
PLoS ONE | www.plosone.org 1 April 2012 | Volume 7 | Issue 4 | e35429including fruits, vegetables and cereals. These molecules display
fungicidal activity by disrupting the mitochondrial tricarboxylic
acid cycle (TCA) through inhibition of the succinate dehydroge-
nase (SDH) enzyme (also called succinate ubiquinone oxidore-
ductase (SQR), EC 1.3.5.1). The official term, as stated by the
Fungicide Resistance Action Committee (www.FRAC.info) for this
fungicidal class is ‘‘SDHIs’’ for succinate dehydrogenase inhibitors.
At the molecular level, carboxamides inhibit ubiquinone reduction
by binding to the ubiquinone binding site (Qp site) of the SDH
enzyme [10]. The SDH enzyme is composed of four polypeptides
which are nuclear encoded. SDHA and SDHB subunits assemble
into the so called soluble catalytic dimer which faces the matrix
whereas SDHC and SDHD subunits form the integral membrane
component anchoring the heterotetrameric enzyme to the internal
membrane of the mitochondria. Catalytic mechanisms by which
electrons are transferred from succinate to ubiquinone involve: (i)
oxidation of succinate at the level of SDHA which carries a
covalent FAD (ii) transfer of electrons through the iron sulfur
clusters [2Fe-2S], [4Fe-4S], and [3Fe-4S] carried by the SDHB
subunit, (iii) two step reduction of the ubiquinone at the so called
Qp site formed by the interface of SDHB SDHC and SDHD
subunits. This later reaction involves transient formation of a semi
quinone radical and the intervention of a heme which forms an
integral part of the complex [11,12,13]. Crystal structures of the
enzyme have been resolved for Escherichia coli [14], Gallus gallus
(chicken) [15] and Sus scrofa (pig) [16].
Carboxin, was the first carboxamide to be developed for crop
protection and was used as seed treatment displaying mainly a
basidiomycete spectrum of control [17,18]. Continuous research
has led to the discovery of new chemical structures which modified
and broadened this initial narrow biological spectrum and
improved potency to the levels required from a modern fungal
control agent. Newly discovered molecules include Penthiopyrad
(Mitsui chemicals), Boscalid (BASF), Bixafen (Bayer), Fluopyram
(Bayer), Sedaxane (Syngenta) and Isopyrazam (Syngenta), some of
which display outstanding performance for STB control in the
field. Even though SDHIs will be used in mixtures with a
maximum of two applications per season in order to minimize the
resistance development risk (FRAC), the almost simultaneous
introduction of compounds displaying similar modes of action will
impose a significant selection pressure on M. graminicola popula-
tions, in particular within European regions of high wheat
production [19]. This further stresses the importance of under-
standing possible resistance mechanisms to better predict the
emergence, spread and persistence of resistance to this class of
fungicides in order to develop effective resistance monitoring and
anti resistance strategies [20]. A number of target mutations have
already been described both in the lab and in the field which can
lead to carboxamide resistance. Artificial mutants with amino acid
substitutions in the SDH genes encoding the Qp site of SDH have
previously been produced in various fungal species including
Ustilago maydis (B_H257L) [21,22], M. graminicola (SDHB_H267L/
Y) [23], and more recently at various loci in Aspergillus oryzae
(SDHB_H249Y/L/N, SDHC_T90I, SDHD_D124E) [24]. A
spontaneous mutant conferring Flutolanil and Carboxin resistance
was also reported and characterized in Coprinus cinereus
(SDHC_N80K) [25]. In all these studies functional confirmation
was obtained by expression of the mutated alleles in the WT
background. In fact it has been suggested that these mutant genes
may provide dominant selection markers that can be used in many
commercially relevant fungal species [24,26,27]. Resistance
towards Carboxin was claimed for barley field isolates of Ustilago
nuda in France, Canada and Italy and the resistance mechanism
although not elucidated was reported as monogenic [28,29]. More
recently, target site mutations which confer Boscalid resistance
have been detected in various species in the field including Botrytis
cinerea [30,31,32] and Alternaria alternata [33,34]. Complex cross
resistance patterns, including negative cross resistance were
reported for Oxathiin Carboxamides in the late nineteen seventies
[35]. Recent investigations performed with highly Boscalid
resistant field isolates of Corynespora cassiicola and Podosphaera xanthii
show that striking lack of cross resistance can be found across novel
carboxamides [36]. A recent cross resistance study performed with
a range of novel M. graminicola mutants which were selected on
Carboxin only confirmed this is also true in M. graminicola [37].
This suggests that commercially introduced carboxamide SDHIs
differ in their binding properties to the SDH enzyme.
The primary aim of this study was to understand possible target
site resistance mechanisms to a range of newly introduced
subclasses of carboxamides in M. graminicola by exploring the
impact of target mutations on compound binding, enzyme
efficiency and pathogen fitness. To this end M. graminicola was
subjected to random UV mutagenesis and 5 structurally distinct
carboxamides were used for selection. The characterization of
more than 480 mutants enabled the identification of as many as 27
substitution types affecting in total 18 positions in the SDHB,
SDHC and SDHD-Qp site forming proteins. Characterization of
the mutants enabled the identification of substitution types that
display selectivity to structurally distinct carboxamides. Docking
studies, using a homology model of M. graminicola SDH, offer
valuable insight to some of the experimental findings. Character-
ization of enzyme efficiencies showed that the ubiquinone
reduction step was impaired in all mutants. Using transgenic
strains expressing mutated copies of the enzyme SDH subunits we
showed that very low levels of SDH activity is required for the
establishment of resistance in vivo. Finally, homologous recombi-
nant gene replacements for the most relevant substitutions types
enabled preliminary fitness studies in vitro and in planta to be
performed. Homologous recombinant strains developed in this
haploid pathogen, correspond to the introduction of a single
mutation in the whole genome enabling us to perform a very clean
comparison of likely biochemical factors affecting fitness. Using
these homologous recombinant strains we unexpectedly found that
M. graminicola Qp site mutations did not significantly impact
reactive oxygen species (ROS) production in vivo. However, in
planta virulence was affected suggesting that these carboxamide
selected Qp site mutations have an impact on the biology of this
pathogen. Our study nicely complements recent results reported
with M. graminicola Carboxin-selected mutants [37], whilst our
modelling approach enables us to propose a more accurate model
of the binding interaction which fits all our more extensive
experimental findings for this class of inhibitors.
Results
Generation of M. graminicola mutants resistant to
carboxamides
Compounds used for selection following UV mutagenesis were
chosen both for structural diversity and relevance to the crop
protection market (Fig. 1).
Two different UV incidences were used for most selection
compounds 75 mJ cm
22 or 50 mJ cm
22 leading to 80% and 50%
lethality after UV treatment respectively. Frequency of resistance
development ranged between 7.2 E
27 for Carboxin at the minimal
selective concentration (MSC, see material and methods) to the
absence of growing colonies for Fluopyram at 56MSC (Table 1).
The strength of UV treatment had a minor impact on resistance
frequency suggesting that mutation rate, increasing with UV
Fungal Target Resistance to Carboxamides
PLoS ONE | www.plosone.org 2 April 2012 | Volume 7 | Issue 4 | e35429Figure 1. Chemical structure of carboxamides used in the study, trivial and IUPAC denominations. The generic structure of
carboxamides can be divided into 3 main parts. (i) the ‘‘acid core’’ which differs from its ring structure: oxathiin (Carboxin), pyrazole (Isopyrazam),
pyrrole (compound A), pyridine (Boscalid), substituted benzene (Fluopyram) (ii) the ‘‘linker’’ which is composed by a benzene ring or a 2-carbon
aliphatic spacer in Fluopyram, (iii) the bulky hydrophobic rest, missing in Carboxin.The aim of the figure legend should be to describe the key
messages of the figure, but the figure should also be discussed in the text. An enlarged version of the figure and its full legend will often be viewed in
a separate window online, and it should be possible for a reader to understand the figure without switching back and forth between this window and
the relevant parts of the text. Each legend should have a concise title of no more than 15 words. The legend itself should be succinct, while still
explaining all symbols and abbreviations. Avoid lengthy descriptions of methods.
doi:10.1371/journal.pone.0035429.g001
Table 1. Mutagenesis experiments overview.
Selection UV treatment Plated cells (10
6) Collected colonies Frequency
Carboxin 85 mM (MSC) 50 90 56 6.2E-07
Carboxin 85 mM (MSC) 75 90 65 7.2E-07
Carboxin 425 mM( 5 6MSC) 50 90 1 1.1E-08
Carboxin 425 mM( 5 6MSC) 75 90 1 1.1E-08
Isopyrazam 3 mM (MSC) 50 90 29 3.2E-07
Isopyrazam 3 mM (MSC) 75 90 37 4.1E-07
Isopyrazam 15 mM( 5 6MSC) 50 90 13 1.4E-07
Isopyrazam 15 mM( 5 6MSC) 75 90 15 1.7E-07
compound A 100 mM (MSC) 50 90 13 1.4E-07
compound A 100 mM (MSC) 75 90 19 2.1E-07
compound A 250 mM( 2 . 5 6MSC) 50 90 19 2.1E-07
compound A 250 mM( 2 . 5 6MSC) 75 90 17 1.9E-07
Fluopyram 25 mM (MSC) 50 90 64 7.1E-07
Fluopyram 25 mM (MSC) 75 90 67 6.3E-07
Fluopyram 125 mM( 5 6MSC) 50 90 0 nd
Fluopyram 125 mM( 5 6MSC) 75 90 2 2.2E-08
Boscalid 30 mM (MSC) 50 50 64 1.3E-06
Boscalid 150 mM( 5 6MSC) 50 1.6 14 8.8E-06
doi:10.1371/journal.pone.0035429.t001
Fungal Target Resistance to Carboxamides
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decreasing with UV exposure, is finely balanced in this range of
survival rates. For all compounds, except Boscalid and compound
A, a pyrrole analogue of Isopyrazam, a decrease in the frequency
of growing colonies was observed with 56MSC selection which is
consistent with higher concentrations of the active ingredient
providing more stringent selection conditions. With Boscalid a
higher frequency of resistance was observed with the 56MSC
selection. However, careful examination of the AE agar plates
supplemented with 150 mM Boscalid (56MSC) displayed white
precipitate which developed over time. Taken together this
suggests that the Boscalid was precipitating in the media and that
the concentration of biologically available Boscalid at the time of
selection was lower in the Boscalid 150 mM supplemented plates
compared to the ones supplemented with Boscalid at 30 mM. No
significant change in the frequency of resistant strain development
could be observed between MSC and 2.56MSC with the pyrrole
carboxamide compound A.
Molecular characterization of carboxamide selected
mutants
Following primary selection, 482 colonies were picked from the
primary selection plates (Table 1) and re-isolated on the same
selective media. Following this process, 30 strains unable to grow
consistently were identified as false positives (Table 2). All other
strains were cultured and sequence analysis of the MgSDHB,
MgSDHC and MgSDHD genes was undertaken. Mutations leading
to amino acid substitutions in the target proteins were detected in
444 out of 452 of the selected strains (98.2%). Target mutations
were identified in all three Qp site encoding subunits and as many
as 27 different substitution types were identified. Rare cases of
double substitutions were observed in SDHB (Boscalid selection),
SDHC (Isopyrazam selection) and SDHD (Carboxin selection).
However, no mutants carrying substitutions in more than one
subunit simultaneously were obtained. The absence of target
mutation was only observed for 8 strains (1.8%). Additional
controls performed on these strains including repeated isolation
under selective conditions and re-sequencing of the four SDH
encoding genes confirmed non target site resistance mechanisms
can be selected under low compound selection pressure.
Selected substitution types appeared to be both compound and
concentration dependent. Interestingly, clear decreases in resis-
tance frequencies were observed for Fluopyram and Carboxin
upon shifting selection from MSC to 56 MSC (Table 1). These
were accompanied by a drastic reduction in the diversity of the
different substitution types (Table 2). For Fluopyram the diversity
of selected substitution types decreased from 13 at MSC to 1 at
56MSC. The most frequent substitution at the MSC
(SDHC_A84V, 57%) was not observed at 56MSC. On the other
hand SDHC_S83G substitution representing only 3.1% of the
mutants at MSC was the only substitution type observed at 56
MSC. Similarly, Carboxin selected 13 substitutions at MSC but
only the SDHB_H267L substitution could be found at 56MSC.
At the MSC, the most frequent substitution conferring Carboxin
resistance was SDHB_H267Y accounting for 57.5% of the
mutants, while SDHB_H267L represented only 6.6% of the
mutants under these conditions. These results suggest that a
diverse range of substitutions can lead to resistance to low levels of
Fluopyram and Carboxin but at the more stringent 56 MSC
selection substitution types leading to lower resistance factors are
eliminated. Although less marked, diversity of substitution types
was also reduced from 5 to 3 and from 5 to 2 with increased
Isopyrazam and compound A selection respectively. When
comparing the substitution types obtained across the different
carboxamides, the substitution patterns were most similar for
Isopyrazam and its pyrrole homologue. For these 2 molecules, the
substitutions SDHB_H267L, SDHC_N86K and SDHC_H152R
were the most frequently isolated. Given the similarity in the
structures of these two carboxamides, similar substitution pattern
might be expected, however the SDHB_H267L substitution was
found much more frequently with Isopyrazam suggesting subtle
differences in the molecular recognition of those two compounds
by the enzyme. Seven of the isolated substitution types were found
in multiple selection conditions, most notably the SDHB_H267L
substitution which was selected with all compounds tested
(Table 2). Interestingly, other substitutions were unique to the
individual compounds used for selection, this was the case for
many mutation types selected with Carboxin (8 out of 12) and with
Fluopyram (9 out of 12). These different substitution patterns
suggest subtle differences in the way the different carboxamide
compounds interact with SDH.
Localization of amino acid substitutions in the primary
structure of SDH proteins
Among the 3 subunits composing the Qp site, SDHB is by far
the most conserved, displaying 57% identity across ascomycetes
sequences used in the alignment (Fig. 2). By contrast SDHC and
SDHD display rather poor primary sequence conservation with
22% and 21% identity respectively across the ascomycetes species
used in the alignment.
Our mutagenesis screen for carboxamide resistance led to the
identification of 18 substituted amino acids, among which 13 were
affecting highly conserved residues of the Qp site. A great
proportion of these residues has been shown to be functionally
involved in ubiquinone binding and reduction catalysis in other
species [13,38,39,40,41].
Two regions prone to substitution could be identified on SDHB,
one between amino acids S218 and P225 and the other between
amino acids R265 and N271. All these SDHB amino acid
positions are strictly conserved across species. On SDHC, one
major region prone to amino acid substitution was identified
between amino acid T79 and V88, with a continuous stretch of
substituted positions between S83 and V88. This later contains the
S83 and R87 highly conserved Qp site residues and four
neighbouring positions which are not conserved across species
(A84, L85, N86 and V88). The nature of the residues present at
these positions may have an influence on Qp site structure and
properties and thus, on the biological profile of carboxamides.
Finally, the H145 and H152 histidines, which are also strictly
conserved across species, were both found substituted with
arginines. On SDHD, D129 was the only substituted position;
together with its neighbouring Y130 these 2 positions represent the
only conserved residues across the whole protein in the SDHD
alignment.
Cellular and mitochondrial sensitivity of resistant
mutants to carboxamides
To explore the sensitivity profiles conferred by amino acid
substitutions at the cellular and mitochondrial level, we deter-
mined sensitivity towards 4 different compounds for 26 of the
identified substitution types both in vivo using liquid culture growth
(AE media) and in vitro using purified mitochondria and the
succinate: Q0/DCPIP activity test (Table 3). To ensure that only
target site resistance was studied, a series of comparative tests with
strains carrying similar target mutations was performed and only
strains that displayed consistent resistance profiles were selected for
further study. One representative strain was selected for all
Fungal Target Resistance to Carboxamides
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PLoS ONE | www.plosone.org 5 April 2012 | Volume 7 | Issue 4 | e35429substitution types apart from SDHB_S221P which seemed to
result in a significant fitness penalty as the two strains carrying this
substitution displayed very significant growth defects. All other
strains displayed similar levels of growth in liquid AE media.
Resistance factors (RF) were determined as the ratio IC50mutant/
IC50WT. The values of in vivo resistance factors for strains selected
on each compound ranged between the following values: 4.4
(SDHC_H145R) to 39.7 (SDHD_D129S) for Carboxin selection,
22.9 (SDHD_D129G) to 464.4 (SDHC_N86K) for Isopyrazam
selection, 5 (SDHB_P220L) to 126.8 (SDHC_S83G) for Fluo-
pyram and 21.7 (SDHB_H267Q) to 564.3 (SDHC_S83G) for
Boscalid. Because of the very poor succinate: Q0/DCPIP activity
displayed by some mutants in vitro, we calibrated our test by
adjusting enzyme concentrations at a similar initial velocity (see
material and methods). As IC50s are dependent on amount of
enzyme used in the test, the ranking of RFs obtained in vivo
compared to the in vitro values can differ notably. For example the
SDHD_D129T substitution which displayed an in vitro RF of 4095
towards Isopyrazam only ranks as the fifth strongest mutation in
vivo (RF: 33). Similar discrepancies between the in vivo and in vitro
rankings can be observed for all of the carboxamides tested.
However, these data enable a comparison of the differential
behaviours displayed towards the 4 carboxamides tested by a given
mutated enzyme. Qp site mutations are well known to influence
SDH enzyme activity and stability upon catalysis, [13,38,41].
Discrepancies observed between the in vivo and in vitro sensitivity
data suggested that the impact of substitutions on enzymatic
activity needed to be addressed to have a fuller understanding of
the factors influencing the resistance displayed in vivo.
Carboxamide pharmacophore elucidation using available
structural information
In order to obtain a clearer understanding of the structural basis
for the differential resistance profiles observed across carboxa-
mides in the SDH mutants, a prediction of the binding modes for
the carboxamides used in this study was required. In order to
generate putative binding modes, all publicly available crystal
structures were analysed in a first step to identify key pharmaco-
phoric features (see material and methods). All crystal structure
ligands are equipped with a hydroxyl or carbonyl group making
hydrogen bonds to B_Trp164 and D_Tyr83 (amino acid
numbering according to E. coli SQR). In the crystal structure
1NEN the quinone ring is sandwiched by B_Pro160 and C_Ile28
[14]. The overlay of all structures onto each other shows that some
ligands are not superimposing exactly on the quinone ring but all
ligands display a scaffold that lie in the same plane (Fig. 3A). This
was partly described already by Horsefield et al. who divided the
binding pocket into a Q1 and Q2 sites [10]. The ligands of the
structures with PDB codes 1NEK, 1NEN, and 2ACZ are
equipped with lipophilic alkyl groups making hydrophobic
interactions at the entrance of the quinone pocket. The alkyl
groups are oriented perpendicular relative to the quinone plane
(Fig. 3A). In carboxin SQR co-crystal structures, the orientation of
the methyl group of the oxathiin ring was a matter of controversy.
Initially it was proposed that the methyl group is oriented towards
C_Ser27 (2FBW) [15] but more recent crystal structure elucida-
tions with both chicken (2WQY) and E. coli SQR (2WDQ)
enzymes demonstrated a 180u flipped oxathiin ring [40].
Moreover, recent structures elucidated with SQR-ubiquinone
binding site inhibitors further confirm this trend. The structure
3AE4 shows that the Br atom, displaying a well defined electron
density, has the same orientation as the methyl in the oxathiin ring
of carboxin. In other structures the CF3, or methyl group were
consistently built on the same side (e.g. PDB code 3ABV, and
3AE5). Mutagenesis and kinetic data have demonstrated the
importance of the conserved SDHC Qp site serine (SDHC_S83 in
M.graminicola, C_Ser27 in E.coli) in ubiquinone binding and
catalysis [13]. In addition, there are two crystal structures with
quinone scaffolds where a hydrogen bond between the ligands and
C_Ser27 could be observed (1YQ3, 1YQ4) [42]. This residue is
proposed to be a key residue interacting with ubiquinone during its
proposed movement within the Qp site during catalysis [10].
Based on the high structural similarity to the carboxamides
described in this study, the interaction observed in the chicken
Carboxin-SQR co-crystal structure 2WQY gives a valuable
indication of the binding mode of carboxamides. In this crystal
structure a hydrogen bond mediated by a water molecule was
observed between the ligand amide NH and the C_Ser27
hydroxyl [15].
Inhibitor docking studies in a M. graminicola SDH
homology model
Utilizing observed protein ligand interactions, putative binding
modes were generated for Boscalid, Isopyrazam, and Fluopyram
(Fig. 3C–E). All three fungicides share similar key interactions
displaying hydrogen bonds to SDHB_W224 and SDHD_Y130
through the amide oxygen and the hydrogen bond of the amide
NH to SDHC_S83 mediated by a water molecule. The
involvement of the SDHC_S83 in the establishment of a hydrogen
bond upon carboxamide binding is supported experimentally by
Figure 2. Localization of substituted amino acids in the SDH subunits of M. graminicola UV mutants and degree of conservation
across species. Asterix indicate substituted residues, conserved residues are shaded in black, dark grey and light grey corresponding to 100%, 80%
and 60% conservation respectively. Sequences are from M. graminicola (Mg), Alternaria alternata (Aa), Alternaria oryzae (Ao), B. cinerea (Bc),
Magnaporthe grisea (Mag), S. cerevisiae (Sc), Ustilago maydis (Um), G. gallus (Gg), S. scrofa (Ss) and E. coli (Ec).
doi:10.1371/journal.pone.0035429.g002
Fungal Target Resistance to Carboxamides
PLoS ONE | www.plosone.org 6 April 2012 | Volume 7 | Issue 4 | e35429T
a
b
l
e
3
.
I
n
v
i
v
o
a
n
d
i
n
v
i
t
r
o
I
C
5
0
s
a
n
d
r
e
s
i
s
t
a
n
c
e
f
a
c
t
o
r
s
o
v
e
r
v
i
e
w
.
I
C
5
0
(
n
M
)
C
a
r
b
o
x
i
n
I
s
o
p
y
r
a
z
a
m
F
l
u
o
p
y
r
a
m
B
o
s
c
a
l
i
d
i
n
v
i
v
o
i
n
v
i
t
r
o
i
n
v
i
v
o
i
n
v
i
t
r
o
i
n
v
i
v
o
i
n
v
i
t
r
o
i
n
v
i
v
o
i
n
v
i
t
r
o
W
T
(
I
P
O
3
2
3
)
6
4
7
0
6
1
0
8
5
1
1
5
6
6
1
0
2
5
5
6
2
5
6
0
.
3
5
8
4
6
1
0
0
4
4
6
2
.
2
4
5
5
6
4
7
6
0
6
1
.
8
R
e
s
i
s
t
a
n
c
e
F
a
c
t
o
r
s
(
R
F
s
)
C
a
r
b
o
x
i
n
I
s
o
p
y
r
a
z
a
m
F
l
u
o
p
y
r
a
m
B
o
s
c
a
l
i
d
S
u
b
s
t
i
t
u
t
i
o
n
S
t
r
a
i
n
i
n
v
i
v
o
i
n
v
i
t
r
o
i
n
v
i
v
o
i
n
v
i
t
r
o
i
n
v
i
v
o
i
n
v
i
t
r
o
i
n
v
i
v
o
i
n
v
i
t
r
o
N
o
n
e
I
P
O
3
2
3
1
1
1
1
1
1
1
1
B
_
S
2
1
8
F
F
l
u
4
1
5
.
3
4
6
.
4
1
5
.
0
1
8
.
2
1
8
.
0
2
7
6
.
5
6
.
5
4
6
.
3
B
_
P
2
2
0
T
F
l
u
1
1
0
0
.
1
0
.
7
3
.
8
1
.
8
1
1
.
5
8
4
.
9
6
.
1
2
8
.
3
B
_
P
2
2
0
L
F
l
u
7
5
1
.
4
4
.
4
4
.
8
1
.
2
5
.
0
3
.
3
2
.
2
2
.
6
B
_
N
2
2
5
H
C
b
x
1
0
6
2
0
.
2
3
8
.
0
1
3
.
6
1
5
.
7
8
.
0
1
5
.
2
1
2
.
2
2
0
.
1
B
_
N
2
2
5
I
F
l
u
7
1
0
.
2
6
.
9
1
5
.
0
7
.
0
1
7
.
5
2
5
.
0
1
2
.
9
1
8
.
5
B
_
R
2
6
5
P
C
b
x
5
6
2
0
.
1
2
7
1
.
1
7
.
6
8
8
.
3
2
.
8
6
3
.
0
1
3
.
3
2
5
6
.
0
B
_
H
2
6
7
L
C
b
x
2
9
1
4
.
5
1
9
5
9
.
3
1
5
2
.
2
3
2
4
8
.
5
2
2
.
4
7
6
6
.
1
2
5
8
.
0
9
1
2
6
.
6
B
_
H
2
6
7
N
C
b
x
9
6
1
2
.
6
2
3
2
.
7
4
.
5
1
1
.
1
9
.
9
6
8
.
3
3
.
4
3
4
.
8
B
_
H
2
6
7
Q
B
o
s
5
9
4
.
4
8
5
.
5
1
2
.
5
3
4
.
6
0
.
9
1
1
.
8
2
1
.
7
1
0
3
4
.
3
B
_
H
2
6
7
Y
C
b
x
2
8
1
4
.
1
6
5
.
9
1
6
.
1
1
4
2
.
6
0
.
6
5
.
1
3
0
5
.
6
4
7
3
.
8
B
_
I
2
6
9
V
C
b
x
1
1
2
.
4
1
9
.
9
5
.
0
3
.
6
1
0
.
0
1
8
.
0
4
.
2
1
2
.
7
B
_
N
2
7
1
K
F
l
u
3
3
2
.
6
1
0
6
9
.
2
5
.
7
8
9
.
5
1
0
.
0
2
4
8
1
.
0
3
.
4
2
2
3
.
7
C
_
T
7
9
I
B
o
s
6
4
5
.
2
6
2
.
0
1
5
.
8
5
6
.
4
2
.
2
1
2
.
3
1
8
.
9
1
4
5
.
6
C
_
S
8
3
G
F
l
u
1
1
0
.
7
1
1
.
7
6
1
.
2
3
8
.
6
1
2
6
.
8
2
0
1
.
0
5
6
4
.
3
1
3
9
2
.
4
C
_
A
8
4
V
F
l
u
4
0
.
8
1
.
2
3
.
5
3
.
1
1
9
.
0
1
0
2
.
7
2
.
6
3
.
7
C
_
A
8
4
I
F
l
u
2
1
1
.
2
1
.
8
8
.
8
8
.
1
3
1
.
9
2
6
0
.
0
2
.
9
4
.
4
C
_
L
8
5
P
C
b
x
1
2
1
1
.
5
2
6
5
.
4
1
0
.
0
3
5
.
3
5
.
8
1
3
0
.
1
4
.
1
3
4
.
7
C
_
N
8
6
K
I
z
m
7
2
3
.
8
1
3
5
.
9
4
6
4
.
4
8
4
9
.
9
4
9
.
9
2
4
5
.
8
7
8
.
1
1
6
0
.
2
C
_
R
8
7
C
F
l
u
9
3
.
2
n
d
*
3
.
7
n
d
*
6
.
1
n
d
*
1
8
.
8
n
d
*
C
_
V
8
8
D
O
l
5
0
4
.
4
6
7
.
2
3
6
.
5
1
4
0
.
4
5
.
9
5
5
.
4
5
.
0
5
9
.
8
C
_
H
1
4
5
R
C
b
x
7
6
4
.
4
n
d
*
2
7
.
6
n
d
*
2
.
0
n
d
*
1
7
.
3
n
d
*
C
_
H
1
5
2
R
I
z
m
1
1
3
.
2
4
5
.
4
1
3
3
.
9
9
5
.
0
1
1
.
5
1
4
.
3
3
0
.
2
5
8
.
1
D
_
D
1
2
9
E
C
b
x
2
2
3
5
.
9
6
3
1
.
6
6
.
8
1
4
5
.
3
1
.
3
1
0
.
5
4
2
.
8
1
2
2
0
.
9
D
_
D
1
2
9
G
C
b
x
6
7
1
7
.
2
2
0
3
0
.
3
2
2
.
9
5
8
3
.
2
5
.
6
1
8
8
0
.
2
3
7
.
1
2
0
5
2
.
4
D
_
D
1
2
9
S
C
b
x
1
0
1
3
9
.
7
3
7
7
.
7
1
0
.
8
8
2
.
5
1
.
9
1
2
.
3
1
5
.
9
3
4
1
.
2
D
_
D
1
2
9
T
F
l
u
2
9
6
0
.
4
F
R
*
*
3
3
.
5
4
0
9
5
.
5
1
1
.
5
3
7
2
4
.
4
7
8
.
3
5
5
1
5
.
8
U
p
p
e
r
p
a
n
e
l
:
I
n
v
i
v
o
a
n
d
i
n
v
i
t
r
o
I
C
5
0
v
a
l
u
e
s
o
b
t
a
i
n
e
d
f
o
r
t
h
e
W
T
(
I
P
O
3
2
3
)
6
S
.
E
.
(
t
r
i
p
l
i
c
a
t
e
)
.
L
o
w
e
r
p
a
n
e
l
:
r
e
s
i
s
t
a
n
c
e
f
a
c
t
o
r
s
(
R
F
s
)
b
a
s
e
d
o
n
I
C
5
0
a
s
s
e
s
s
m
e
n
t
f
o
r
a
s
e
l
e
c
t
e
d
s
u
b
s
e
t
o
f
r
e
p
r
e
s
e
n
t
a
t
i
v
e
s
t
r
a
i
n
s
.
P
r
e
s
e
n
t
e
d
v
a
l
u
e
s
a
r
e
b
a
s
e
d
o
n
t
h
e
r
a
t
i
o
o
f
t
h
e
m
e
a
n
s
o
f
t
h
r
e
e
i
n
d
i
v
i
d
u
a
l
d
e
t
e
r
m
i
n
a
t
i
o
n
s
f
o
r
t
h
e
i
n
v
i
v
o
v
a
l
u
e
s
a
n
d
b
a
s
e
d
o
n
t
h
e
r
a
t
i
o
o
f
a
s
i
n
g
l
e
d
e
t
e
r
m
i
n
a
t
i
o
n
f
o
r
t
h
e
i
n
v
i
t
r
o
v
a
l
u
e
s
.
P
r
e
s
e
n
t
e
d
i
n
v
i
t
r
o
v
a
l
u
e
s
w
e
r
e
o
b
t
a
i
n
e
d
b
y
c
a
l
i
b
r
a
t
i
n
g
m
i
t
o
c
h
o
n
d
r
i
a
l
d
i
l
u
t
i
o
n
s
t
o
o
b
t
a
i
n
s
i
m
i
l
a
r
i
n
i
t
i
a
l
v
e
l
o
c
i
t
y
(
s
e
e
m
a
t
e
r
i
a
l
a
n
d
m
e
t
h
o
d
s
)
.
C
b
x
s
t
r
a
i
n
s
w
e
r
e
o
r
i
g
i
n
a
l
l
y
o
b
t
a
i
n
e
d
o
n
C
a
r
b
o
x
i
n
s
e
l
e
c
t
i
o
n
m
e
d
i
a
,
F
l
u
o
n
F
l
u
o
p
y
r
a
m
,
B
o
s
o
n
B
o
s
c
a
l
i
d
,
I
z
m
o
n
I
s
o
p
y
r
a
z
a
m
,
O
l
o
n
p
y
r
r
o
l
e
c
o
m
p
o
u
n
d
A
.
n
d
*
:
I
C
5
0
c
o
u
l
d
n
o
t
b
e
d
e
t
e
r
m
i
n
e
d
b
e
c
a
u
s
e
f
i
t
t
e
d
c
u
r
v
e
s
w
e
r
e
n
o
t
t
e
n
d
i
n
g
t
o
1
0
0
%
i
n
h
i
b
i
t
i
o
n
a
t
i
n
f
i
n
i
t
e
A
I
c
o
n
c
e
n
t
r
a
t
i
o
n
.
F
R
*
*
(
f
u
l
l
r
e
s
i
s
t
a
n
c
e
)
,
n
o
s
u
f
f
i
c
i
e
n
t
i
n
h
i
b
i
t
i
o
n
d
e
t
e
c
t
e
d
a
t
h
i
g
h
e
s
t
i
n
h
i
b
i
t
o
r
c
o
n
c
e
n
t
r
a
t
i
o
n
t
e
s
t
e
d
.
d
o
i
:
1
0
.
1
3
7
1
/
j
o
u
r
n
a
l
.
p
o
n
e
.
0
0
3
5
4
2
9
.
t
0
0
3
Fungal Target Resistance to Carboxamides
PLoS ONE | www.plosone.org 7 April 2012 | Volume 7 | Issue 4 | e35429the high resistance factors (up to 564 fold in vivo) observed across all
ligands with the SDHC_S83G mutant. The acid part of all
carboxamides (oxathiin, pyrazole, phenyl and pyridine) is
sandwiched between C_Arg87 and B_Ile269 and form Van-der-
Waals interactions to SDHB_I269, and cation-p interaction to
SDHC_R87. The SDHC_R87C mutation abolishes the cation-p
interaction; in vivo, this mutation conferred only limited carbox-
amide sensitivity decrease (RFs between 3.2 and 18.8). In vitro, the
effect of the SDHC_R87C substitution on enzyme inhibition
looked more complex as only partial inhibition could be reached at
maximal concentration of the inhibitor despite of an otherwise
WT like response. The SDHB_I269V mutation also conferred
Figure 3. Tridimensional model of the M. graminicola SDH with Qp site docked carboxamides and interactions to substituted
residues. A: Superposition of all complex II crystal structures with a resolution higher than 3 A ˚. Only amino acids that are in a 5 A ˚ radius to the
bound ligands in the quinone binding site are shown. Amino acids and the heme are represented in lines, the ligands in sticks and water molecules as
non bonded spheres. The color code is presented according to atom types. Amino acid and heme carbons are colored in green, ligands carbons in
salmon. B: putative binding mode of carboxin in a tridimensional model of M.graminicola SDH. The heme carbons are represented in cyan sticks, the
carboxin carbon atoms in salmon. Amino acids that are involved in resistance after mutation are colored in dark blue, amino acids that make key
interactions are shown in green and amino acids that are in close proximity to the ligand but which were not found substituted in this study are
colored in grey. Hydrogen bonds are shown as yellow dotted lines. C: Putative binding mode of Boscalid in M.graminicola SDH. D: Putative binding
mode of Fluopyram in M. graminicola SDH. E: Putative binding mode of Isopyrazam in M. graminicola SDH. F: Model of M. graminicola SDH where
SDHB histidine 267 is mutated into a tyrosine. The putative binding mode of the mutated enzyme with Carboxin is shown.
doi:10.1371/journal.pone.0035429.g003
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PLoS ONE | www.plosone.org 8 April 2012 | Volume 7 | Issue 4 | e35429limited resistance factors (ranging between 4 to 20 fold in vitro). A
valine can still compensate for some of the lipophilic interactions
carried out by SDHB_I269. The ortho substituents of the acid
parts (methyl in Carboxin, CF2 in Isopyrazam, CF3 in
Fluopyram, and Cl in Boscalid) are pointing towards SDHB_S221
which corresponds to the orientation suggested by Ruprecht et al
[40].
SDHB_R265 and SDHD_D129 are not involved in direct
interactions to the ligands according to the binding models but
form a hydrogen bond network with the heme and the imidazole
ring of SDHB_H267. SDHB_H267 is positioned at the bottom of
the Qp site. Depending on the organism this residue either makes
a direct hydrogen bond to SDHD_D129 (observed for all G. gallus
and S. scrofa SQR crystal structures) or to one heme propionate
(observed for all E. coli SQR structures). By analyzing the electron
density for the histidine sidechain it was suggested that this amino
acid can adopt multiple conformations [10]. In our proposed
binding modes for M. graminicola SDH, SDHB_H267 makes a
direct hydrogen bond to SDHD_D129 and edge to face stacking
to the four different inhibitors. However, an alternative binding
mode can be hypothesized, where a direct hydrogen bond of the
histidine to the pyridine of Boscalid, to the pyrazole of
Isopyrazam, and to the oxathiin of Carboxin occurs. In this case
SDHB_H267 cannot make direct hydrogen bonds to
SDHD_D129 or one heme propionate anymore. This alternative
is supported by the recently solved crystal structure of the E. coli
SQR enzyme containing the histidine to threonine substitution
(PDB code 2WP9). In this study, the complex II was shown to
remain stable and active in a case where neither a hydrogen bond
to the heme propionate nor to SDHD_D129 are formed [43]. A
mutation of B_H267Y leads to high in vitro resistance factors for
Boscalid (RF=473.8), Isopyrazam (RF=142.6), and Carboxin
(RF=65.9). In order to understand this in more detail a model for
M. graminicola SQR with the SDHB_H267Y substitution was
generated (Fig. 3F). The aromatic sidechain makes edge to face
stacking to the inhibitors and the tyrosine hydroxyl group a
hydrogen bond to SDHD_D129. In this configuration, a direct
hydrogen bond of the tyrosine to the hydrogen bond accepting
groups of Boscalid, Isopyrazam, and Carboxin is unlikely
potentially impairing the binding of these molecules and thereby
explaining the higher resistance factors observed for these
molecules. Moreover, this model would predict the low resistance
towards Fluopyram which is not equipped with an acceptor group
and Carboxin with the second lowest resistance factor (in vivo
RF=14.1) is equipped with the weakest accepting group followed
by Isopyrazam and Boscalid.
SDHB_P220 is a fully conserved Qp site residue sandwiching
the quinone ring together with a residue corresponding to
SDHC_A84 in all ubiquinone-SDH co-crystal structures
[14,15,16]. In the binding models, the proline displays hydropho-
bic interactions with the amine part of the carboxamides (aliphatic
linker in Fluopyram; phenyl group in Carboxin, Boscalid, and
Isopyrazam). In vitro, resistance factors are in a single digit range
except for Fluopyram (RF=85) and Boscalid (RF=28) with the
SDHB_P220T mutant. SDHC_A84 is predicted to interact via
Van-der-Waals forces with the aliphatic linker of Fluopyram and
the pyridine ring. This aliphatic linker is a specific feature of
Fluopyram compared to the other carboxamides analysed in this
study. The linker is in the z-dimension sterically more demanding
and is getting closer to SDHC_A84 compared to phenyl ring
systems of Carboxin, Boscalid, and Isopyrazam. In agreement with
these predictions, Fluopyram binding is found to be specifically
affected by the SDHC_A84V/I substitutions as shown by over 30
fold higher RFs in vitro compared to the phenyl ring carboxamides.
Furthermore, higher resistance factors are observed with the
bulkier amino acids substitution, SDHC_A84I which is in line
with the proposed interaction. Interestingly, the amino acid at
SDHC_A84 position is not conserved across fungal species and
may contribute to some of the biological profile observed for these
carboxamide subclasses.
The SDHB_W223, SDHC_L71, and SDHC_W80 residues, are
all in Van-der-Waals distance to the amine part of all ligands.
However, no substitutions at these positions were observed in this
study. The substituted residues, SDHB_S218, SDHB_N225,
SDHB_N271; SDHC_T79, SDHC_L85, SDHC_N86,
SDHC_V88, SDHC_H145, and SDHC_H152 are not predicted
to directly interact with carboxamides but amino acid substitutions
more distant from the binding pocket may influence the shape and
electronics of the Qp site and therefore have a negative impact on
ligand binding. A putative long-range effect and/or a rearrange-
ment of a large zone affecting part of the Qp site is particularly
likely for the SDHC_H145 position which was substituted by an
arginine upon Carboxin selection as this is the furthest substituted
residue from the Qp site. Despite a distance of ,10 A ˚ to the
closest atom of docked Carboxin, the SDHC_H145 is a ligand of
the heme and therefore may influence the Qp site structure and/
or properties. According to available SDH crystal structures, the
propionate side chains of the heme can be considered part of the
Qp site. Furthermore, it was shown that the heme itself directly
participates in electron transfer during catalysis [11]. In yeast and
in E. coli, modification of the coordinated histidine impairs
ubiquinone binding and catalysis efficiency of the SDH enzyme
[39,42,44]. Therefore, the SDHC_H145R substitution in M.
graminicola may influence heme properties and/or positioning
which in turn might have a negative impact on inhibitor binding.
SDHC_N86K and SDHC_H152R were the most frequent
substitutions upon Isopyrazam and compound A selection. Both
were also selected by Boscalid but less frequently and the
SDHC_N86K substitution was also found upon Fluopyram
selection. In the M. graminicola tridimensional SDH model, these
residues are not predicted to directly interact with the inhibitor yet
are in the close vicinity to the heme, again making a direct
influence on heme positioning possible.
Enzyme efficiency determination
To compare specific activities conferred by the different amino
acid substitutions we first determined the level of SDH enzyme in
mitochondrial preparations for each of the resistant strains
(Table 4). SDH enzyme carries a covalently bound FAD at the
succinate oxidation site located within the SDHA subunit [45], this
feature enables the accurate quantification of the SDH enzyme
even in complex samples [46]. Overall, covalent FAD values
differed at most by a factor 4 between samples, suggesting that the
strains carrying less active SDHs are not compensating for this
effect by overexpression of the enzyme. This result was further
validated by western blot using anti M. graminicola SDHB
antibodies (data not shown).
The malonate sensitive succinate: PMS/MTT activity test is
classically considered as a measurement of the SDHA-B dimer
[47]. This activity does not require the functional reduction of the
ubiquinone at the Qp site and was accordingly not affected upon
carboxamide addition in M. graminicola [48]. Activity levels varied
greatly among mutants, ranging between 46% and 179% of the
WT enzyme activity. A wide range of effects could be observed
even when substitions affected similar position as observed with
the SDHB_H267Y and SDHB_H267N which displayed succi-
nate: PMS/MTT activities of 40% and 117% of the WT activity
respectively. Interestingly, mutations on SDHC and SDHD also
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site has not been identified yet, we suspect that electron
distribution within the enzyme might be affected in our SDH
mutants, which could in turn favour or disfavour reduction of this
substrate at its reduction site(s) [43,47,49]. Similar variations have
also been reported for other Qp site mutations in other studies
[41,50].
In vivo, the electrons derived from succinate have to be
transferred to its acceptor (ubiquinone) to enable the enzymatic
oxidizing of novel molecules of succinate. The succinate: Qo/
DCPIP activity is a measure of the succinate: ubiquinone
reductase activity, which is the most relevant one biologically. In
vitro, full inhibition of the WT enzyme can be reached using all
four carboxamides compared in this test.
All mutants displayed weaker ubiquinone reductase activity
compared to the wild type. The weakest effect was detected for the
SDHC_A84V mutant which was 87% as active as the WT. The
strongest impairment was displayed by the SDHB_N271K mutant
with only 5% residual activity. As might be expected, different
substitutions at the same residue can result in differential impact
on enzyme efficiency. This effect seems to be linked to the degree
of steric or physico chemical conservation displayed by the
substitutive amino acid. For example, the SDHD_D129E
conservative substitution maintains 42% of WT activity whiles
the non conservative SDHD_D129G/S/T substitutions impact
enzyme activity much more strongly (from 6 to 23% remaining
activity). The same observation can be made for the SDHC_A84V
variant which is more active (87%) than the SDHC_A84I (51%)
counterpart which carries a larger substituent.
The straight comparison of the in vivo log IC50 estimates and in
vitro log IC50 estimates across the different strains for any given
compound displayed reasonable correlation for each of the four
compounds considered here (Fig. 4A). We attempted to correct
IC50 values using enzyme efficiency as a correction factor for total
amount of enzyme used in the tests. Interestingly, using this
simplified adjustment (see Figure 4 legend); the correlations
between in vitro and in vivo log IC50 were improved for all
compounds (Fig. 4B). However depending on the Ki and Km
values displayed by each mutant, the relationship between IC50
and amount of enzyme can be complex and a determination of
Table 4. Enzymatic efficiencies determinations for selected subset of strains representative of each mutation type.
Mutation Strain Covalent FAD
a MTT/PMS activity
b Q0/DCPIP activity
c
none IPO323 330.3623.6 474 662 (100%) 484.4154407 642 (100%)
B_S218F Flu41 344.4614 416 667 (88%) 92.87292759 618 (19%)
B_P220T Flu110 378.064.7 720 6110 (152%) 107.7682646 69 (22%)
B_P220L Flu75 304.565.8 717 684 (151%) 231.8025324 616 (48%)
B_N225H Cbx106 299.563.8 850 6175 (179%) 334.8801055 633 (69%)
B_N225I Flu7 281.0614.2 651 698 (137%) 188.7997691 619 (39%)
B_R265P Cbx56 363.1619.7 217 653 (46%) 41.7782216 610 (9%)
B_H267L Cbx29 519.5610.4 381 637 (80%) 64.57824113 67 (13%)
B_H267N Cbx96 246.764.3 553 677 (117%) 94.85037408 615 (20%)
B_H267Q Bos59 453.868.5 334 640 (70%) 65.25108944 66 (13%)
B_H267Y Cbx28 438.4625.5 190 644 (40%) 45.65897328 618 (9%)
B_I269V Cbx1 387.2621.0 545 6147 (115%) 416.7898614 673 (86%)
B_N271K Flu33 286.967.8 218 626 (46%) 25.98331188 65 (5%)
C_T79I Bos64 241.963.0 501 670 (106%) 124.887427 616 (26%)
C_S83G Flu1 368.6612.4 714 697 (151%) 286.9379225 634 (59%)
C_A84V Flu4 229.669.1 850 6119 (179%) 419.0858506 659 (87%)
C_A84I Flu21 631.5615.4 596 695 (126%) 245.6437942 632 (51%)
C_L85P Cbx12 320.8624.9 334 656 (70%) 143.5533934 628 (30%)
C_N86K Izm7 284.766.6 407 686 (86%) 200.6388817 635 (41%)
C_R87C Flu9 333.569.3 389 646 (82%) 117.638248 612 (24%)
C_V88D Ol50 200.567.8 838 6170 (177%) 139.7192089 621 (29%)
C_H145R Cbx76 377.8627.2 555 698 (117%) 97.84219544 612 (20%)
C_H152R Izm1 156.768.8 227 634 (48%) 106.7682223 622 (22%)
D_D129E Cbx22 211.467.6 491 6123 (104%) 202.5551707 630 (42%)
D_D129G Cbx67 180.963.8 808 680 (171%) 91.9077442 69 (19%)
D_D129S Cbx101 453.868.5 534 684 (113%) 111.2427749 617 (23%)
D_D129T Flu29 253.9610.5 568 669 (120%) 29.33687605 66 (6%)
aCovalent FAD is expressed in pmol covalend FAD mg of protein
21 and is an estimation of the total amount of succinate dehydrogenase enzyme present in the
mitochondrial preparation, presented values are the average of four individual determinations 6 S.D.
bMTT/PMS activity expressed as mmol PMS reduced MTT min
21 mmol covalent FAD
21. Values represent the means of at least 10 determinations 6 S.D.
cQo mediated DCPIP reduction expressed in mmol reduced DCPIP min
21 mmol covalent FAD
21 in the presence of 1 mM Qo. Values represent the means of at least 10
determinations 6 S.D.
doi:10.1371/journal.pone.0035429.t004
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further improve the correlation factor applied here [51]. In
addition to enzyme efficiency, stability upon catalysis [42,50] and
modification of preferred substrate [43] are factors which might
also have an influence on the establishment of resistance in vivo.
In vivo and in vitro sensitivity comparison between
ectopic transformants and homologous recombinants
carrying resistant alleles
To explore the influence of SDH mutations in vivo in more detail,
we introduced ectopic expression cassettes in the M. graminicola
IPO323 WT strain creating a strain which is artificially heterozy-
gous for a particular SDH gene (Materials and Methods, Fig. 5B).
Corresponding homologous recombinant (HR) strains where the
wild type SDH gene was replaced with the mutant form were also
generated for comparison. These HR events were fully character-
ized molecularly, confirming the presence of a unique mutation in
the whole genome differentiating the WT strain (IPO323) from its
corresponding homologous recombinants (cf Materials and
Methods). The ectopic transformant Tr_SDHB_H267L ex-
presses a mixture of both sensitive (SDHB_WT) and resistant
(SDHB_H267L) SDHB containing enzymes. As a result, the
mitochondrial Boscalid inhibition curve is biphasic reflecting the
two populations of enzymes present (Fig. 5A). The WT enzyme is
inhibited at low doses but mitochondrial activity is maintained at
higher doses indicating the contribution of mutated enzyme to the
mitochondrial activity in this transformant. Interestingly, in the
ectopic transformant expressing SDHB_H267L (Tr B_H267L), the
total SDH activity which can be attributed to the mutated enzyme
(see Fig. 5A, remaining activity at WT inhibiting concentrations) is
much lower than the one attributable to the WT SDH. Despite its
lower contribution to the total SDH activity in the mitochondria,
clear dominance of the mutated allele can be seen in vivo using liquid
culture tests (Fig. 5C). However, resistance levels reached by
TrH267L strains remained significantly lower (unpaired t test,
p,0.01) compared to the one reached by the corresponding
homologous recombinant HR_H267L strains. This effect was not
restricted to SDHB, as similar results were obtained with the
SDHC_A84V mutation towards Fluopyram (Fig. 5D, also p,0.01).
These results may indicate competition between the WT and
mutated subunit for assembly into the functional enzyme in the
mitochondria of the ectopic transformants. This assumption is
further supported by the observed carboxamides oversensitivity
displayed by ectopic transformants expressing non functional
subunits (data not shown, [48]). This would explain the weaker
phenotype seen with the ectopics carrying less mutated enzyme
compared to the pure mutant.
Taken together, our results confirmed that total SDH activity
level remaining upon carboxamide inhibition is the driver for cell
survival. Despite the major loss in SDH enzyme efficiency observed
in many of the mutants compared to the WT (Table 4), here we
show that very low levels of activity are sufficient to confer survival
upon carboxamide treatment (compare Fig. 5A and Fig. 5C). This
suggests that in vivo, carboxamide inhibitors have to almost
completely block SDH enzymatic activity in order to deliver their
fungicidal effect.
Generation of homologous recombinants for most
relevant mutation types
To fully explore a potential fitness cost conferred by SDH
mutations we generated homologous recombinant strains for some of
the strongest and most frequent substitutions types. The following
substitutions were selected for further analysis: SDHB_R265P and
SDHB_I269V uniquely obtained upon Carboxin selection at MSC,
SDHB_H267Y most frequent substitution occurring mutant follow-
ing selection at the MSC for Carboxin and Boscalid, SDHB_H267L
leading to high resistance levels towards all classes in vitro,
SDHC_S83G leading to the strongest Fluopyram and Boscalid
resistance in vivo, SDHC_A84V being the most frequent mutation
occurring upon Fluopyram selection at MSC and conferring specific
resistance to this compound and SDHC_N86K and SDHC_H152R,
strongest and most frequent mutations found with Isopyrazam
selection. As shown in figure 6, the 9 HR strains displayed similar
growth on non selective AE media even though some pigmentation
difference can be noticed. Similar growth behaviour was maintained
on a minimal media (data not shown). The strength of growth
obtained on SDHIs amended media correlated well with the in vivo
resistance factors obtained using their corresponding UV mutants in
liquid culture test (Table 3) validating these target mutations fully
conferred observed cross resistance profiles.
Figure 4. Scatter plot presenting in vivo LogIC50 (nM) versus in vitro LogIC50 (nM) adjusted (B) or not (A) for enzyme efficiency. All
data extracted from table 3 and adjusted for amount of enzyme used in the sensitivity test in panel B. Adjustment was performed using enzyme
efficiency data extracted from table 4 following a simple equation: if percent efficiency is denoted by E then the efficiency adjusted IC50=observed
IC506E/100. Following this adjustment the correlation was improved for all compounds.
doi:10.1371/journal.pone.0035429.g004
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stresses
During catalysis, the Qp site of SDH is responsible for the 2 step
electron transfer from the [3Fe-4S] iron sulphur cluster of SDHB to
the ubiquinone substrate. The reaction involves the formation of a
transient ubisemiquinone radical which is stabilized by electron
transfer to the heme [13]. SDH Qp site mutants of Saccharomyces
cerevisae and E. coli have been reported to display increased
superoxide radical formation [38,41,52]. SDH Qp site mutations
can also affect lifespan of organisms by causing a continuous
oxidative stress which has been associated to premature aging and
tumor formation [52,53,54,55]. Mutations of the Qp site residues
corresponding to SDHB_P220, SDHC_A84 and SDHD_D129 in
M. graminicolahavebeen shown to confer increasedROSproduction
and oxidative stress hypersensitivity in other organisms including E.
coli [38], Caenorhabditis elegans [52,53], and S. cerevisae [41]. To assess
whether carboxamide-selected Qp site mutations isolated in this
study display a similar impact on oxidative stress sensitivity in M.
graminicola we compared sensitivity of a subset of the generated
homologous recombinant strains to various oxidative stresses. Two
superoxide inducing conditions were used, treatment with 10 mM
Paraquat (methylviologen), a herbicide reported toinduceoxidative
stress through the generation of superoxide anions and a continuous
100% oxygen atmosphere simulating hyperoxia. Paraquat supple-
mented media had a similar impact on growth of both the
homologous recombinant strains and the WT (Fig. 7A, middle
panel). UV strains representative of all mutations types (excluding
SDHB_P221 mutants, strongly impaired in growth) were tested
using same conditions but did not display any clear difference in
growth (data not shown). Similarly, hyperoxia simulated by a
continuous 100% oxygen atmosphere showed a very minor
Figure 5. Comparison of the resistance phenotypes displayed by transformants of the SDHB or SDHC subunits. Two types of
transformants were created, (i) Tr strains where the genes encoding either SDHB or SDHC subunits were ectopically inserted under the control of a
GPDA promoter, (ii) HR strains where the WT gene was replaced by a mutated version in its original genomic context. A: SDH inhibition displayed by
mitochondrial extracts as measured with the succinate: Q0/DCPIP reduction test in the presence of varying concentrations of Boscalid. Fitted curve is
monophasic with the ectopic transformant containing the WT SDHB expression cassette (black dots) and with the homologous recombinant strain
carrying the SDHB_H267L mutation (HR B_H267L, black triangles). Inhibition is biphasic with the ectopic transformant containing the SDHB_H267L
expression cassette (Tr B_H267L, black squares). B: Southern blot of genomic DNA extracted from (left to right), the WT (IPO323), one ectopic
transformant carrying the WT_SDHB expression cassette, one ectopic transformant carrying the SDHB_H267L expression cassette and signal obtained
with one SDHB_H267L homologous recombinant. Boscalid (C) and Fluopyram (D) resistance phenotypes displayed by ectopic and homologous
recombinants transformants. In both cases when additional WT SDHB (Tr_WT_SDHB) and SDHC (Tr_WT_SDHC) were inserted ectopically, no
significant increase in resistance was observed. When an additional mutated copy of SDHB (Tr_SDHB_H267L) or of SDHC (Tr_SDHC_A84V) was
inserted ectopically, significant resistance to the compounds was observed, clearly indicating a dominant effect of the mutated alleles. However, in
the homologous recombinant strains where only the mutated subunit SDHB (HR_SDHB_H267L) or SDHC (HR_SDHC_A84_V) was present a further
increase in resistance is observed. Whiskers represent minimum and maximum RFs obtained, boxes represent 95% confidence interval and bars value
of the median. The data presented correspond to average values of duplicated tests with four independent events of each kind.
doi:10.1371/journal.pone.0035429.g005
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mutants (Fig. 7A, lower panel). This suggests that all carboxamide
selected SDH mutations have no or a minor influence on ROS
production in M. graminicola in vivo. When hydrogen peroxide was
used as a further oxidative stress inducer and the data subjected to
analysis of variance, again no significant shift in the sensitivity
towards this oxidizing agent could be detected across WT and HR
strains (p.0.1) (Fig. 7B). This result is further supporting these
carboxamide-selected M. graminicola SDH mutations have a minor
or no oxidative stressrelated fitnesspenalty in vivo. To evaluate ROS
production in the mitochondria of SDH Qp mutants in vivo,w eu s e d
the intracellular ROS indicator MitoSOX
TM Red (Molecular
Probes). As could be expected from the lack of hypersensitivity to
oxidative stressesin previousin vivo tests,comparison of oursubset of
homologous recombinant strains showed no clear evidence for a
difference across the WT and the target mutants (p.0.1) (Fig. 7C).
However, in all conditions tested, fluorescence intensity remained
very low, even hydrogen peroxide and Paraquat driven changes in
fluorescence signal were not significantly higher than WT. Poor
signals were also obtained with the cytosolic ROS marker
dihydroxyethidium bromide (DHE, Molecular probes) (data not
shown). These results may be caused by a poor uptake of these small
molecules by the fungal cells or highlight a very good defence
against oxidative agents in this pathogen.
Impact of SDH mutations on necrosis symptom
development in planta
In order to evaluate the impact of SDH mutations on in planta
growth, a smaller subset of the recombinant strains was compared
for necrosis symptoms displayed in planta. For comparing the diverse
SDH mutants we used various homologous recombinant strains
carrying SDHB_H267L, SDHC_H152R, SDHC_N86K and
SDHC_A84V mutations. Homologous recombinant strains were
similarly inoculated on the sensitive WT plant Riband and in planta
symptoms assessed visually 14 days after inoculation (Fig. 8). The
data were subjected to analysis of variance which detected clear
evidence of differences amongst strains (p,0.01). The statistical
significance of differences between the WT and each of the HR
Figure 6. Comparative growth of homologous recombinant strains on various carboxamide amended media. Allstrains were grownon
AE agar supplemented (or not) with the indicated active ingredient (final concentration indicated). Cell suspensions obtained from 4 days old V8 agar
plates were serially diluted by 10 fold factor steps in liquid AE and 2 ul were spotted onto the plates. Pictures were taken 10 days post inoculation for
carboxamides amended plates and 6 days post inoculation for AE plate. Pictures were taken from same plates and reordered for visualization.
doi:10.1371/journal.pone.0035429.g006
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HR strains displayed significantly higher symptomology compared
to the WT (p,0.05). Furthermore, no difference was seen between
strains carrying a similar SDH mutation (p.0.1 in all cases)
confirming these in planta phenotypes are fully SDH driven.
Interestingly, comparison of these results with those in table 4
shows that the magnitude of necrosis symptoms are not correlating
to SDH activity impairment as quantified by the succinate: Qo/
DCPIP activity test. For example the SDHC_S83G mutants
displayed a similar increase in symptomology compared to the
SDHB_H267L mutants in spite of their different impact on enzyme
efficiency (mutations conferring 59% and 13% residual activity
respectively). Similarly the SDHC_H152R mutants (22% residual
activity) displayed similar necrosis size compared to SDHC_A84V
mutants (84% residual activity), and to the SDHC_N86K mutant
(41% residual activity). This result suggests mutations in the SDH
enzyme have an impact on the biology of the pathogen.
Discussion
In this study, we developed a better understanding of the
binding properties and resistance mechanisms for a range of new
carboxamides recently introduced as crop protection fungicides.
The different biological spectrum displayed by the new carbox-
amides demonstrates that an incredibly broad range of biological
Figure 7. Absence of a major oxidative stress related fitness penalty in M. graminicola homologous recombinant strains carrying Qp
site mutations. A: Respiratory growth of wild type and mutants in the presence of oxidative stresses. Upper panel, AE agar plate growth, middle
panel: AE agar supplemented with 10 mM Paraquat, lower panel: AE agar plates were placed in a constant 100% atmosphere. All plates were
incubated in same room at room temperature for 6 days. B: Sensitivity towards hydrogen peroxide in liquid AE media. Values presented are the
averages from replicates within 3 individual experiments. C: Evaluation of mitochondrial ROS produced in vivo as determined with MitoSOX
TM Red
fluorescent indicator. Evaluations based on values from over 3 replicates within 3 individual experiments. +PQ corresponds to 1 mM Paraquat
supplementation during the incubation period, +H2O2 correspond to 10 mM H2O2 supplementation during the incubation period. WT (IPO323), and
homologous recombinant strains HRAV: SDHC_A84V, HRDG: SDHD_D129G, HRHL: SDHB_H267L, HRHR: SDHC_H152R, HRHY: SDHB_H267Y, HRIV:
SDHB_I269V, HRNK: SDHC_N86K, HRRP: SDHB_R265P, HRSG: SDHC_S83G.
doi:10.1371/journal.pone.0035429.g007
Figure 8. Comparison of in planta necrosis symptoms displayed
by individual homologous recombinant strains carrying muta-
tions conferring resistance to carboxamides. Data presented
correspond to the individual means (average of 12 leaves each) of 3
individual experiments 6 S.D. Numbering corresponds to individual
homologous recombinants strains carrying: HRHL1, 4 and 8:
SDHB_H267L substitution, HRSG1 and 2: SDHC_S83G substitution,
HRHR1 and 4: SDHC_H152R substitution, HRNK1: SDHC_N86K substi-
tution, HRAV1, 2 and 3: SDHC_A84V substitution.
doi:10.1371/journal.pone.0035429.g008
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comparing enzyme inhibition and biological profiles, we have
previously found that biological activity is primarily driven by the
affinity of a molecule to the SDH enzyme in targeted organisms
[48]. Poor conservation in residues belonging to subunits SDHC
or SDHD surrounding the Qp site of SDH is observed across
fungal species. One of the challenges in delivering good
agrochemical solutions from carboxamide chemistry has been to
overcome this variation in order to deliver an effective balance
between binding efficacy and fungal spectrum. Partly because of
this wide structural variation in the target enzyme, a unique
solution enabling the control of all fungal pathogens could not be
found. Therefore, further SDHIs that display additional fungicide
spectrum might be introduced in the coming years.
Our mutagenesis study led us to identify 27 different
substitution types affecting 18 positions in 3 of the 4 subunits
encoding the Qp site of the target SDH enzyme. The pattern and
frequency of mutations selected was found to be highly dependent
on the compound used for selection. Accordingly, sensitivity
profiles are substitution dependent, as a result of specific
interaction of different classes of inhibitors to specific structural
features of the enzyme. The large majority of the mutations lead to
a sensitivity decrease across all carboxamides in vivo, but the level
of reduced sensitivity shows a high degree of variation across the
carboxamide/substitution pairs studied. More practically, this
suggests that the use of carboxamides of different structures to
control the same pathogens will strongly influence the nature and
composition of the mutant population in the field as was found in
A. alternata field trials [56].The nature of carboxamide-selected M.
graminicola target mutations found in the laboratory display striking
similarities with the mutations found in B. cinerea field populations
following several years of Boscalid usage [30,32]. Among the
various substitutions detected in B. cinerea field isolates the
SDHB_H272Y/L, SDHB_P225L/T and SDHB_N230I substitu-
tions correspond to SDHB_H267Y/L, SDHB_P220L/T and
SDHB_N225I carboxamide-selected substitutions respectively in
M. graminicola. This shows that carboxamide resistance can be
conferred by similar substitutions at similar positions within the
structure of the SDH enzyme across species. Contrasting with the
SDHB_P225L/T substitutions conferring high levels of resistance
towards Boscalid and Fluopyram in B. cinerea ([30], Syngenta,
unpublished result). In our screen, the M. graminicola
SDHB_P220L/T substitutions were obtained upon Fluopyram
selection only and conferred limited resistance towards this active
ingredient as well as weak Boscalid resistance (Table 3). Therefore,
subtle differences in the structure of the Qp site of SDH within
targeted organisms are likely to influence the nature of
substitutions conferring resistance to a given carboxamide and
this highlights the problems in extrapolating resistance prediction
from one pathogen to another. This is further exemplified by the
different substitution patterns and associated resistance factors
displayed by A. alternata pistachio field isolates after a few years of
Boscalid usage [33,34]. Despite the difficulties in extrapolating
between species some key conserved interactions are beginning to
emerge. For example, Fluopyram hypersensitivity is observed in
SDHB histidine to tyrosine Qp site mutants in a range of species
including M. graminicola (SDHB_H267Y), B. cinerea
(SDHB_H272Y) and A. alternata (SDHB_H277Y) ([30,56], Syn-
genta, unpublished results). A similar substitution may also explain
the similar negative cross resistance behavior observed in some
Boscalid resistant isolates of C. cassiicola and P. xanthii [36]. Using
the homology model developed in this study, a possible
explanation for this conserved negative cross resistance was
proposed. In the WT enzyme, a key H-bond interaction may
occur between the rotated histidine of the Qp site and the acceptor
group of Boscalid. This crucial interaction for binding is removed
by the tyrosine substitution which consequently impairs Boscalid
binding in the mutant. Contrastingly, Fluopyram which has no H-
bond acceptor group does not rely on this specific interaction for
binding and is then unaffected by the histidine to tyrosine
substitution. Further confirming this assumption, compound A
which also lacks a H-bond acceptor group gives also better control
of the M. graminicola SDHB_H267Y mutant compared to the WT
(data not shown). Given the degree of conservation for cross
resistance profiles seen with this particular mutant it seems that the
depicted interaction is consistently conserved across species.
Using transformation we evidenced that the remaining SDH
activity present in the cells at a given inhibitor concentration is
responsible for survival. Interestingly, very low levels of SDH
activity were sufficient for the establishment of resistance, as
confirmed by the selection of substitutions leading to over 90% loss
in activity. This suggests that for each mutant, in vivo survival upon
carboxamide treatment is a balance between a negative impact
brought by decreased enzyme activity/stability caused by
substitutions affecting the Qp site and a positive one brought by
poorer binding of carboxamide inhibitors resulting in weaker
inhibition of the enzyme. From a cellular perspective and
considering the central role of SDH for energy production, it
seems logical that the remaining SDH activity, which is necessary
to maintain an active TCA cycle, is the driver for survival.
A balance between substrate and inhibitor binding would
explain why some highly conserved residues of the Qp site which
are predicted to be essential for carboxamide inhibitor binding in
the tridimensional model were neither found substituted in our
screen nor reported yet in field populations. Notably the fully
conserved Qp site residues SDHB_W224 and SDHD_Y130 which
are predicted to hydrogen-bond to the amide oxygen of
carboxamides [15,40]. In agreement with the essential involve-
ment of the conserved SDHD tyrosine in the establishment of a
crucial hydrogen bond to one quinone oxygen, E. coli,
SDHD_Y83F and S. cerevisae SDHD_Y89F substitutions impair
85% and 95% of the ubiquinone reductase activity respectively
[13,57]. We introduced the SDHD_Y130F substitution in the M.
graminicola MgSDHD gene using site directed mutagenesis and
found that ectopic transformants expressing SDHD_Y130F are
more sensitive to carboxamides compared to the WT (data not
shown). The absence of any mutation at this residue for all
carboxamides tested might indicate that substitutions at this
position could not confer selective advantage in the balance
between catalysis and inhibition.
Because SDH enzyme activity was impaired in all mutants we
expected to find some degree of fitness penalty in vivo.
Furthermore, similar Qp site substitutions have been shown to
have biological influence on the lifespan of organisms through the
increased production of ROS by the mutated SDH enzyme
[38,41,52,53,54,55]. To primarily address this and to prevent the
likely interference caused by mutations in other genes in UV
mutants, we generated homologous recombinants to some of the
most relevant substitution types. The absence of any significant
growth defect in our carboxamide-selected Qp site mutants and
homologous recombinant strains suggested that the likely
increased ROS production by the mutated enzyme was not
exceeding the capacity of the antioxidant defense system in M.
graminicola. One explanation for this result may be that our initial
selection for carboxamide resistance is strongly biased against the
selection of mutants which display high level of oxidative stress.
This could occur if the presence of ROS producing mutations
impacted growth as shown with many yeast Qp site mutants on
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resulted in the absence of identifiable colonies at the point of
colony selection. Carboxamide-selected Qp site substitutions were
all leading to decreased ubiquinone reductase activity suggesting
that, at least in some cases, the stability of the transient ubiquinone
semiradical generated during the course of the reaction might be
affected and thus lead to locally increased ROS production [38].
Therefore, the absence of strong oxygen hypersensitivity pheno-
types is surprising and may be explained by a combination of
factors. First the specific activity displayed by M. graminicola SDH is
10 times lower compared to that of S. cerevisiae SDH [41]. More
generally, M. graminicola is a slow growing pathogen and might
have a much lower mitochondrial ROS production rate compared
to fast growing fungi like S. cerevisiae. Secondly, M. graminicola is a
hemibiotrophic pathogen and therefore has to survive plant
induced oxidative burst in colonized plant tissue. The pathogen
requires and induces an exceptionally efficient ROS detoxification
enzyme toolset in order to survive the necrotrophic stage of its
lifecycle [58]. In fact it has been suggested that ROS production
by M. graminicola itself and ROS signalling may also contribute to
pathogenicity [58,59]. Therefore, the combination of a slower
turnover with the presence of an extraordinary large enzymatic
toolset capable of defend against ROS in this species might lead to
the very poor impact of oxidative stresses towards carboxamide-
selected Qp site mutants when compared to other species. These
hypotheses are further supported by the poor fluorescence signals
obtained with intracellular ROS indicators showing that no
significant ROS accumulation occurs in both WT and mutants. In
vitro tests with a purified mitochondrial fraction will be required to
measure the potentially increased production of ROS by the
mutated M. graminicola SDH enzyme in more detail [38,41,52].
This and further work would be required to understand the
marked differences in ROS generation and sensitivity between M.
graminicola and other species.
In our test conditions, in planta virulence tests performed with
some of the HR strains showed that some of the SDH mutations
can lead to increased symptoms in the absence of carboxamide
treatment. The reason for this remains unclear, but the increased
symptomology observed in the climatic room is unlikely to result in
increased fitness in the field as nature would have selected such
SDH variants during the course of evolution if it was the case. One
explanation for the observed phenotype is that the presence of less
efficient SDH enzyme might lead to increased intracellular levels
of succinate as observed in yeast mutants [41] and in M. graminicola
WT upon treatment with sub-lethal doses of carboxamides (data
not shown). In yeast, perturbations of the succinate dehydrogenase
function have a large impact on metabolism. Moreover, it was
shown that succinate dehydrogenase mutations displaying similar
impairment in quinone reductase activity can lead to very distinct
metabotypes [60]. The metabolic impact of impairments of the M.
graminicola SDH enzyme may lead to developmental effects on in
planta growth and symptoms development as complex regulation of
metabolic fluxes have been shown to play a major role in the
infection process [58,61,62]. Necrotrophic growth involves
massive expression of transporters and of enzymes involved in
primary metabolite uptake and degradation and it is very likely to
involve secondary metabolites (small molecules toxins) production
[58,61,62]. Modifications in primary metabolism might have an
influence on this metabolic switch and potentially increase
secretion of small toxin molecules thus explaining the observed
increased symptomology. Even though the reasons for this
increased symptomology in planta remain elusive, our data indicate
that SDH mutations can have an influence on the biology of the
pathogen. Aside additional fitness penalty and resistance studies to
be performed in planta, the question as to know whether this
phenomenon is influenced by ROS or TCA metabolites or both
will require further evaluations now rendered possible by the
homologous recombinants generated during the course of this
study.
Finally, our data clearly shows that a combination of factors
might have to be considered for a diagnosis of mutations likely to
occur in the field. In our mutagenesis screen, high resistance
factors, frequency of occurrence and maintained in planta growth
point towards some mutations for which sensitive molecular tests
will be designed and applied in the monitoring of field populations.
These results combined with the resistance situation in other
pathogens further stress the importance of a proper anti-resistance
strategy for the SDHIs fungicides. At this point in time and in
order to prolong the efficacy of this class of fungicide in wheat,
recommendations include restrictions in the number and timing of
applications as well as the mandatory usage of mixtures (see www.
FRAC.info).
Materials and Methods
Strains, media and culture conditions
M. graminicola isolate IPO323 was used for all experiments [63].
The isolate was inoculated from stocks stored in liquid nitrogen
onto solid V8 agar [64]. Yeast like cells were harvested from these
plates and used immediately as an inoculum for all experiments.
The following media were used throughout: Aspergillus minimal
medium (AMM) [64]; TSM40 (4 g glucose, 10 g malt extract, 4 g
yeast extract, pH 7.0); AE medium [23]; induction medium (IM)
[64]; potato dextrose agar (PDA) [64]. DH5a or ccdB survival cells
(Invitrogen) were used for the maintenance of plasmids in E. coli.
Agrobacterium. tumefaciens strain EHA105 [65,66], was used for
maintenance of constructs and for A. tumefaciens mediated
transformation.
Carboxamides, mutagenesis and UV mutant isolation
Minimal selective concentration (MSC) is the minimal concen-
tration of carboxamide necessary to fully inhibit growth of the wild
type IPO323 M. graminicola strain after inoculation of AE agar
plates with 10
7 cells followed by incubation for 2 weeks at 20uCi n
the dark. Selection plates were produced after adding 1% of a
1006DMSO solution of the active ingredients to pre-melted AE-
agar. A higher concentration corresponding to 56 MSC was
applied with Carboxin, Isopyrazam, Fluopyram and Boscalid and
2.56MSC with the Isopyrazam pyrrole analogue compound A.
Cells were harvested from 4 days old V8 agar plates and
conidial cells were suspended in liquid AE. 10
7 cells were spread
onto carboxamide amended AE agar plates and mutagenized
using UV Stratalinker 2400 (Stratagene) with 75 mJ cm
22 or
50 mJ cm
22. These UV treatments produce lethality of 80% and
50% respectively. Selection plates were incubated in the dark at
20uC for 14 days. Visible colonies were picked from the primary
selection plate and re-grown on fresh selection media for 2
additional weeks under the same conditions.
Molecular characterization of UV mutants
Strains were grown in 5 ml liquid TSM40 on a reciprocal
shaker (220 rpm, 20uC) for 5 days prior to genomic DNA
extraction using a Qiagen mini plant kit (Qiagen). PCR primer
design was based on the M. graminicola IPO323 genome sequence
[63]. The four SDH-encoding genes were PCR amplified and
sequenced using primers listed in Table S1. For comparison
purposes, SDHB, SDHC and SDHD proteins sequences were
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Production of M. graminicola transformants
For ectopic integration of SDH subunit expression cassettes, the
multisite binary pNOV2114_gateway vector was used with the A.
nidulans gpda (glyceraldehyde-3-phosphate dehydrogenase) pro-
moter to drive the expression [64]. Wild type or mutated MgSDH
gene were amplified from genomic DNA using PfuTurbo-DNA
polymerase (Stratagene) and two rounds of amplification with
primers listed in table S1. The attB PCR fragments were cloned
into pDONRzeo plasmid (Invitrogen). Finally, multiple gateway
reaction was performed using multisite Gateway cloning (Invitro-
gen) to produce pNOV_gpda_MgSDHB_TrpCter, pNOV_gp-
da_MgSDHB-H267L_TrpCter, pNOV_gpda_MgSDHC_TrpCter,
and pNOV_gpda_MgSDHC-A84V_TrpCter plasmids.
For homologous recombination, genomic fragments containing
part of the SDH gene without the start codon but containing the
mutation(s) leading to the specified amino acid substitution plus
,800 bp down-stream of the gene were PCR amplified using
primers described in Table S1 and cloned into the multiple cloning
site of pNOV2114 vector [67,68]. Oligonucleotides were designed
to avoid in-frame start codons upstream of the cloned fragment.
M. graminicola transformation procedure has been described
previously [64]. For isolation of homologous recombinants,
selection of transformants was performed on AE agar supple-
mented with an appropriate carboxamide. Three rounds of
selection were applied. Absence of the start codon in the
homologous recombination constructs ensured low frequency of
functional expression from ectopic insertions.
Molecular characterization of transformants
For ectopic transformants, primer pairs were designed to screen
for the presence and completeness of the gpda promoter, MgSDH
gene and hygromycin resistance gene. For homologous recombi-
nants, primer pairs were generated to verify the unique presence of
the mutated copy using differential restriction profiles displayed by
the mutated allele versus the non mutated allele. In addition
primer pairs were designed to screen for the absence of T-DNA
downstream of the integrated fragment. All strains which passed
PCR verification were sequence verified. All PCR primers and
details mentioned above are listed in Table S1.
The copy number of the SDH gene in the transformed strains
was assessed by Southern blot. Hybridization probes were
produced by PCR amplification of the SDH gene of interest and
labeled using the AlkPhos Direct
TM system (GE Healthcare).
Genomic DNA (,10 mg) were digested using BamH1 for SDHB
and SDHD transformants; BamH1/EcoR1 for SDHC transfor-
mants. Digested DNA was electrophoresed and subsequently
blotted and UV cross-linked to Hibond
TM Nylon membranes (GE-
Healthcare) [69]. Hybridization was performed using AlkPhos
Direct
TM reagents (GE-Healthcare). A hybridization temperature
of 55uC was used for labeling all three SDH genes, followed by
washes at 55uC( SDHC and SDHD)o r6 0 uC( SDHB). Lumines-
cence signal was generated with CDP-Star (GE-Healthcare) and
visualized on Kodak Biomax light films (Sigma).
Mitochondria isolation
Strains were grown in 1 liter TSM40 units. Cultures were
inoculated at 0.05 OD600 nm and grown on a reciprocal shaker
(110 rpm, 22uC) for 5 days. Cells were harvested by vacuum
filtration and disrupted in liquid nitrogen using a mortar and
pestle. Resultant powder was re-suspended to 10% w/v in
mitochondrial extraction buffer (10 mM KHPO4 pH7.2; 10 mM
KCl, 10 mM MgCl2, 0.5 M sucrose, 0.2 mM EDTA, 2 mM
PMSF). Extract was clarified by centrifugation (5,000 g, 4uC for
10 minutes, 2 times), intact mitochondria were then pelleted at
10,000 g for 20 minutes at 4uC. The pink-reddish pellet was re-
suspended in a small volume (1 ml for 10 grams initial fresh
weight) of extraction buffer. This volume was transferred to
conical 1.5 ml tubes and re-centrifuged, 10,000 g for 10 minutes
at 4uC. The pellet separates into two layers; the upper reddish
colored being easily re-suspended by pipetting is composed of
nearly pure mitochondria as assessed by microscopy. Subsequent
sucrose gradient centrifugation did not improve specific activity of
the mitochondrial fractions; therefore the purification procedure
was stopped at this stage. Mitochondrial suspensions were brought
to a final concentration of 10 mg ml
21 in extraction buffer and
stored at 280uC until used. SDH activity was found to remain
stable for months.
Enzyme assays
Mitochondrial suspensions were incubated at 30uC for 30 min-
utes in extraction buffer supplemented with 10 mM succinate
prior to enzymatic measurements.
Succinate: ubiquinone/DCPIP measurements were performed
by adding 5 ml of pre-activated mitochondria to 100 ml assay
buffer (50 mM Phosphate-Na pH 7.2, 250 mM sucrose, 3 mM
NaN3, 10 mM succinate) supplemented with 140 mM Dichlor-
ophenolindophenol (DCIP) and 1 mM of 2,3-dimethoxy-5-
methyl-1,4-benzoquinone (Q0), from a 0.1 M DMSO stock
solution. A reaction plate was equilibrated for 10 minutes at
30uC before starting the reaction. DCPIP reduction was
conducted at 30uC and monitored at 595 nm using a HTS7000
microtiterplate reader (Perkin Elmer). For calculations a molecular
extinction coefficient of e=17mM
21 cm
21 was used [70].
The succinate: PMS (Phenazine methosulfate) coupled reduc-
tion of MTT ((4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide) measurements were performed using final concentra-
tions of 400 mM PMS and 150 mM MTT freshly diluted in assay
buffer (50 mM Phosphate-Na pH 7.2, 250 mM sucrose, 3 mM
NaN3, 10 mM succinate). Reactions were started with the addition
of 5 ml of preactivated mitochondrial suspension to 100 ml of the
reaction mixture at 30uC using an experimental setup similar to
DCPIP measurements. The MTT reduction was monitored by
reading the absorbance increase at 570 nm using a HTS7000
microtiterplate reader (Perkin Elmer). For calculations a molecular
extinction coefficient of e=21mM
21.cm
21 was used [71].
In the succinate: ubiquinone/DCPIP test, activity displayed by
some mutants was so low that an adjustment for enzyme activity
was necessary for accurate IC50 determination. For this reason, all
mitochondrial suspensions were adjusted to a similar initial
velocity (1 OD595 nm hour
21) following conditions described
above. Inhibitor concentrations ranged between 1 mM and
0.95 nM with uniform 46 dilution factor steps (11 inhibitor
concentrations+DMSO control). 96 wells plates were pre equili-
brated at reaction temperature (30uC) for 10 minutes before the
reactions were started by the addition of 5 ml preactivated M.
graminicola mitochondrial suspension. Calculated absorbance slopes
(OD/hour) were used for IC50 calculations using Graphpad Prism
5.0 software non linear curve fitting against log inhibitor
concentrations.
Flavin Quantification
Fluorometric quantification of the covalent FAD of SDH was
carried out as described in [72] using 1 mg of protein as starting
material.
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SQR subunits were modelled by using SQR crystal structures
from three different species as templates: E. coli SQR co-
crystallized with the natural substrate ubiquinone-2 at a 2.60 A ˚
resolution (PDB code 1NEK) [14]; G. gallus (chicken) SQR in
complex with the inhibitor carboxin resolved at 2.10 A ˚ (PDB code
2FBW) [15]; S. scrofa (pig) SQR cocrystallized with ubiquinone-2 at
2.40 A ˚ (PDB code 1ZOY) [16].
ClustalW [73] was used to align the individual M. graminicola
SDH protein sequences with the bacterial (1NEK), the avian
(2FBW) and the porcine (1ZOY) protein subunits. The alignments
were analyzed and edited in the Prime 1.5 workflow within the
Maestro environment (Schro ¨dinger, LLC, Portland, OR) [74]. In
contrast to SDHA and SDHB, the alignments of the SDHC and
SDHD anchoring subunits of M. graminicola displayed limited
identity with the sequences of the three crystallographic templates.
Therefore, to further improve the alignments, the multiple
template strategy together with a secondary structure prediction
(SSPro4.0 [75]) was applied. In the next step, the actual three-
dimensional models of each four subunits were built according to
the standard superimposition and side-chain orientation of Prime
protocols. The individual sub-models were then assembled by
superimposition on the 2FBW structure keeping carboxin inside
the Qp site as well as the heme, the FAD and malate-like
intermediate inside the so-called ‘‘substrate binding site’’ to help in
the definition of pockets and cavities. The refinement module of
Prime (PLOP, Protein Local Optimization Program [76]) was used
to optimize the sidechain conformations with particular attention
given to the SDHB, SDHC and SDHD interfaces and other
regions in the vicinity of Qp-site. Moreover default loop
refinement method was performed on sections coating the Qp-
site, 256–271, 226–234 on SdhB and 62–78 on SdhC subunits.
The final M. graminicola SQR model was optimized within the
OPLS2005 force field in Prime [74,77].
Pharmacophore elucidation. All SDH crystal structures
were extracted from the Protein Data Bank (PDB) and
superimposed onto each other. The Qp binding sites of the
superimposed structures with a resolution higher than 3 A ˚ were
visually analyzed in more detail for common pharmacophoric
features (PDB codes 3AE4, 3AEF, 2WQY, 2H88, 2H89, 1YQ3,
1YQ4, 2FBW, 1ZOY, 1NEK, 1NEN, 2WDQ, 2WP9, 2WU5).
Molecular Docking. Carboxin was manually placed in the
Qp binding site of MgSDH with Moloc [78] in an analogous way
as observed in the carboxin G.gallus SQR complex crystal structure
2WQY. In a second step the protein ligand complex was
minimized using Moloc MAB force field [78], allowing full
flexibility for the ligand and keeping the M. graminicola SQR
protein rigid.
Boscalid, Fluopyram, and Isopyrazam were manually docked
into the M. graminicola SQR Qp binding site. Interactions to key
residues which were determined through the pharmacophore
elucidation (see results) were formed. In a second step the protein
ligand complexes were minimized using Moloc MAB force field
[78], allowing full flexibility for the ligands and keeping the M.
graminicola SQR protein rigid.
Mutated Qp-site modeling. Mutations were generated
within the M. graminicola SQR homology model with the ‘‘mutate
residue’’ procedure included in Maestro (Schro ¨dinger, LLC,
Portland, OR), followed by a contact analysis involving multiple
rotamers and a geometry sanitation within the OPLS2005 force field.
In vivo tests forstrain sensitivity determination. Conidial
cells were collected from 4 day old V8 agar plates (cultured at 18uC
in the dark) using liquid AE and a cell spreader. Cell density was
determined and cells re-suspended to a concentration of 5610
5 cells
ml
21 in AE media. Sterile 96 wells microtiter plates with lids
(Costar) were inoculated with 198 ml of this cell suspension (10
5 cells
per well) and 2 ml of inhibitor (1006 in DMSO). Final inhibitor
concentrations were between 0.95 nM and 1 mM with uniform 46
dilution factor steps (11 inhibitor concentrations+1 DMSO control).
Plates were incubated for 6 days at 19uC in the dark before cells
were re-suspended and measured for growth (OD600 nm). IC50
values were determined by non linear curve fitting on the basis of
measured OD values versus log inhibitor concentrations (GraphPad
Prism 5.0 software).
In vivo mitochondrial ROS production assay
Conidial cells were collected from 4 day old V8 agar plates
(cultured at 18uC in the dark) using 2 ml of assay buffer (PIPES
10 mM pH 7.2, 2% w/v glycerol) and a cell spreader. Cell density
was determined and cells re-suspended to a concentration of
3610
7 cells ml
21 in assay prior to their incubation for 2.5 hours in
the dark in the presence of 5 mM MitoSOX red (Invitrogen). After
the incubation period, 200 ml aliquots of each cell suspension were
distributed (3 replicates per strain) into 96well plates (AcroWell
TM
96 filter plates) equipped with 0.45 mm filters (Pall life sciences).
First step of centrifugation 500 g for 3 minutes eliminated non
incorporated fluorescent dye. Cells were resuspended in 200 ml
assay buffer and same centrifugation procedure was applied.
Finally, cells were resuspended in 110 ml assay buffer and 100 ml
were transferred to clear bottom/black framed 96 wells Optilux
TM
plates (Becton Dickinson) for measurement. Fluorescence was
measured with an Enspire 2300 multimode reader (Perkin Elmer)
using lexc of 510 nm and lem of 580 nm (well scan mode, 100
flashes/read, 25 reads/well).
In planta pathogenicity test
Conidial cells were collected from 4 day old V8 agar plates
(cultured at 18uC in the dark) using 2 ml of de-ionized water. Cell
density was determined and cells re-suspended to a concentration
of 10
6 cells ml
21 in de-ionized water supplemented with 0.05%
Tween 20. Each spore suspension was used for the inoculation of
three pots of two weeks old wheat (var. Riband) plantlets (3 to 4
plants/pot). The plants were homogenously sprayed and covered
with a Plexiglas chamber for incubation at 100% humidity for
48 hours at 24uC in the dark. After this incubation period, pots
were placed in a climatic room with alternation periods of 8 hours
darkness (18uC), and 16 hours light (24uC), with 60% constant
humidity. Evaluation of symptoms was performed 16 days after
inoculation by visually estimating the percentage of 2
nd leaf area
covered with pathogen–related necrosis symptoms. Negative
controls (uninfected plants) confirmed the absence of necrosis at
the evaluation time.
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